Stone X Group Inc. Zoetis Inc. Transaction History

Stone X Group Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$148.29 - $182.55 $14,532 - $17,889	98 Added 6.85%	1,528 $227,000
Q2 2022 Jul 27, 2022	BUY	$155.97 - $200.09 $223,037 - $286,128	1,430 New	1,430 $246,000
Q1 2022 May 11, 2022	SELL	$181.39 - $234.03 $233,267 - $300,962	-1,286 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$193.69 - $247.03 $249,085 - $317,680	1,286 New	1,286 $314,000
Q3 2021 Oct 20, 2021	SELL	$189.29 - $209.69 $217,494 - $240,933	-1,149 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$155.9 - $187.99 $179,129 - $216,000	1,149 New	1,149 $214,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

Stay updated on Stone X Group Inc. with notifications on news.